Stock screenerAll disclosures →
EDGAR →
ANGO
Conviction 89HealthcareScan · Tue, Sep 8, 2026ANGO$15.24+0.26%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 300.18K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price15.24
Change+0.26%
Gap-0.99%
Rel volume1.43×
Avg volume360.44K
Avg $ vol5.66M
SMA 2015.74
SMA 5014.65
SMA 20012.25
Price vs 50+4.03%
Price vs 200+24.44%
MA stackbullish
50/200 cross—
Supertrendup · 14.66
RSI (14)48
MACD hist-0.16
MACD cross—
Stoch %K / %D27 / 26
ADX (14)29
+DI / −DI18 / 19
RSI divergence—
MACD divergence—
ATR %+3.27%
ADR %2.99%
52w high16.13
52w low9.70
From 52w high-5.52%
Above 52w low+57.11%
New 52w highNo
SqueezeOn · 6d
Bollinger width5.69%
%B-0.05
Donchian pos27.08%
Donchian high16.29
Donchian low14.85
AVWAP (52w high)15.65
vs AVWAP high-2.65%
AVWAP (52w low)13.01
vs AVWAP low+17.10%
OBV trendFlat
Chaikin MF (20)0.08
Today vs 20d1.43×
Avg vol (14d)300.18K
Avg vol (20d)360.44K
Avg $ vol (20d)5.66M
Market cap629.91M
RS 3m (vs SPY)+22.88%
RS 6m (vs SPY)+25.80%
RS line new highNo
Trend template8/8
Technical rank72.0
1 week-5.52%
1 month-2.87%
3 months+27.75%
6 months+41.37%
1 year+42.03%
YTD+20.19%
P/E-17.14
P/B3.69
P/S1.97
P/FCF1239.97
EPS-0.8800
Div yield—
ROE-21.51%
ROA-13.75%
Debt/Eq0.73
Current2.19
EV/EBITDA-41.27
Gross margin54.62%
Net margin-11.48%
Rev growth9.46%
EPS growth-8.09%
Price target21.00
Target upside37.80%
Analyst ratingBuy
Institutional102.54%
Ent. value700.45M
Revenue78.42M
Net income-8.08M
Gross profit41.48M
Free cash flow508K
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out41.32M
Employees675
ListedThu, May 27, 2004
Free float38.65M
Float %93.8%
Short interest1.35M
Days to cover2.5d
Short volume34.7%
Squeeze score26 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.07 vs −$0.11
Last surprise+36.4% beat
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank72.0 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.23
Support13.28
Days since event—
Candle confirm—
News sentiment—
Financials as of Sat, Feb 28, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ANGO · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Debbie Wasserman Schultz house · D · FL · traded 2025-10-20 | Sell | ≥ $2K | 2025-10-20 | 2025-10-24 | |
Debbie Wasserman Schultz house · FL · traded 2025-10-20 | Sell | ≥ $2K | 2025-10-20 | 2025-10-21 | |
Debbie Wasserman Schultz house · D · FL · traded 2025-06-27 | Buy | $1K–$15K | 2025-06-27 | 2025-07-25 | |
Debbie Wasserman Schultz house · D · FL · traded 2025-07-16 | Sell | $1K–$15K | 2025-07-16 | 2025-07-25 |
Insider activity
SEC Form 4 transactions in ANGO · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Weiss Lawrence T SVP, Chief Legal Officer · Common Stock · 2026-07-15 | Grant | 21.29K | — | 2026-07-15 | 2026-07-22 |
Weiss Lawrence T SVP, Chief Legal Officer · Performance Right · 2026-07-15 | Grant | 21.29K | — | 2026-07-15 | 2026-07-22 |
Campbell Chad Thomas SVP/GM, Vascular Access · Common Stock · 2026-07-15 | Grant | 16.08K | — | 2026-07-15 | 2026-07-22 |
Campbell Chad Thomas SVP/GM, Vascular Access · Performance Right · 2026-07-15 | Grant | 16.08K | — | 2026-07-15 | 2026-07-22 |
Nighan Warren JR SVP Quality and Regulatory · Common Stock · 2026-07-15 | Grant | 17.97K | — | 2026-07-15 | 2026-07-22 |
Nighan Warren JR SVP Quality and Regulatory · Performance Right · 2026-07-15 | Grant | 17.97K | — | 2026-07-15 | 2026-07-22 |
Piccinini Laura SVP International · Common Stock · 2026-07-15 | Grant | 19.86K | — | 2026-07-15 | 2026-07-22 |
Piccinini Laura SVP International · Performance Right · 2026-07-15 | Grant | 19.86K | — | 2026-07-15 | 2026-07-22 |
Trowbridge Stephen A EVP and CFO · Common Stock · 2026-07-15 | Grant | 53.26K | — | 2026-07-15 | 2026-07-22 |
Trowbridge Stephen A EVP and CFO · Performance Right · 2026-07-15 | Grant | 53.26K | — | 2026-07-15 | 2026-07-22 |
SEC filings
EDGAR filings in ANGO · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.